SEMS for EUS-CDS reported a slight superiority of LAMS over SEMS, especially in terms of safety, although this did not reach statistical significance: the authors reported similar pooled rates of technical and clinical success (94.8% vs. 92.7% and 93.6% vs. 91.7%, respectively) and pooled rates of procedure-related adverse events and overall adverse events (6.2% vs. 12.2% and 17.1% vs. 18.3%, respectively).
1
—
—